인쇄하기
취소
|
On the 2nd, Daewoong Pharmaceutical officially announced a KRW 72.8 billion exclusive sales agreement of ‘Pitavastatin Calcium Tab’ in 4 East Asian countries, including Thailand, with the global pharmaceutical company, Abbott.
The upfront payment includes royalties and 10-year collective exports, and Abbott will exclusively sell the product in 4 East Asian countries. The amount accounts for 8....